← FDA DRUG APPROVALS

FDA NDA · NDA019854

DEPEN

penicillamine

Sponsor: MYLAN SPECIALITY LP

APPLICATION
NDA019854
TYPE
NDA
ORIGINAL APPROVAL
1978-11-08
LATEST ACTION
1994-08-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

DEPEN · ReferencePrescription
PENICILLAMINE 250MG · TABLET · ORAL

Approval history

1994-08-17Manufacturing (CMC) · Supplement 6 · standardAP
1993-10-22Manufacturing (CMC) · Supplement 5 · standardAP
1990-06-07Manufacturing (CMC) · Supplement 4 · standardAP
1988-12-22Labeling · Supplement 3AP
1986-11-10Manufacturing (CMC) · Supplement 2 · standardAP
1978-11-08Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →